Kaleida Health logo

Quality and Patient Safety
Percent of Inpatient Pediatric Asthma Patients Given Systemic Corticosteroids

Percent of Inpatient Pediatric Asthma Patients (age 2 to 17 years) Given Systemic Corticosteroids to Treat an Asthma Exacerbation

Guidelines for the diagnosis and management of asthma in children recommend the use of systemic corticosteroids to gain control of acute asthma exacerbation and reduce severity as quickly as possible in children with mild, moderate and severe persistent asthma. This measure reports the overall number of pediatric asthma patients, age 2 through 17 years, who received systemic corticosteroids during hospitalization. A systemic corticosteroid is a medication used to reduce airway inflammation and control moderate to severe asthma symptoms.

A higher percentage, or score, is good because it means more patients received the recommended treatment. However, a lower score does not necessarily indicate poor care. You should consider the overall quality of a facility in addition to individual category scores.

Relievers for Inpatient Asthma (2 to 17 years)

Systemic Corticosteroids for Inpatient Asthma (2 to 17 years)

Inpatient Children's Asthma Care: Composite Process Score

Inpatient Children's Asthma Care: Appropriate Care Score